[HTML][HTML] Cytomegalovirus transmission in mismatched solid organ transplant recipients: Are factors other than anti-viral prophylaxis at play?

C Hernandez, C Mabilangan, C Burton… - American Journal of …, 2021 - Elsevier
Although antiviral prophylaxis has reduced cytomegalovirus (CMV) DNAemia and disease
in seronegative solid organ transplant (SOT) recipients (R-) receiving seropositive donor …

Human cytomegalovirus: a survey of end-organ diseases and diagnostic challenges in solid organ transplant recipients

G Contreras, D Ho - Current Opinion in Organ Transplantation, 2022 - journals.lww.com
The utility of PCR to diagnose CMV end-organ disease is limited. As CMV can infect any
organ system (s), clinicians caring for SOT recipients need to maintain vigilance for any …

Impact of high MELD scores on CMV viremia following liver transplantation

SR Freedman, K Saunders, ME Plazak… - Transplant Infectious …, 2023 - Wiley Online Library
Introduction Advanced liver disease or cirrhosis is associated with an increased risk of
infections; however, the impact of high pretransplant model for end‐stage liver disease …

[PDF][PDF] Aus der Klinik und Poliklinik für Allgemein-, Viszeral-und Transplantationschirurgie der Universitätsmedizin der Johannes-Gutenberg-Universität Mainz

C Scholz - openscience.ub.uni-mainz.de
1 Aus der Klinik und Poliklinik für Allgemein-, Viszeral- und Transplantationschirurgie der
Universitätsmedizin der Johannes Page 1 1 Aus der Klinik und Poliklinik für Allgemein …

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

RWM Vernooij, M Michael, M Ladhani… - Cochrane Database …, 2024 - cochranelibrary.com
Background The risk of cytomegalovirus (CMV) infection in solid organ transplant recipients
has resulted in the frequent use of prophylaxis to prevent the clinical syndrome associated …